Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1084
Embargo will expire:
22-Aug-2018 5:00 PM EDT
Released to reporters:
20-Aug-2018 2:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 22-Aug-2018 5:00 PM EDT

Shark.jpg

Article ID: 699162

Like Shark Attack and the Lottery, Unconscious Bias Influences Cancer Screening

University of Colorado Cancer Center

Doctors with personal experience of cancer are more likely to act against established guidelines to recommend that low-risk women receive ovarian cancer screening.

Released:
17-Aug-2018 12:15 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    17-Aug-2018 11:00 AM EDT

Article ID: 698976

Better Access to Quality Cancer Care May Reduce Rural and Urban Disparities

Fred Hutchinson Cancer Research Center

When enrolled in a cancer clinical trial, the differences in survival rates between rural and urban patients are significantly reduced, SWOG study results show.

Released:
14-Aug-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Embargo will expire:
21-Aug-2018 11:00 AM EDT
Released to reporters:
16-Aug-2018 2:00 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 21-Aug-2018 11:00 AM EDT

Article ID: 699109

Lowering pH Inside Cells May Put the Brakes on Cancer Growth

Moffitt Cancer Center

A new study focusing on the environment inside cancer cells may lead to new targeted treatment strategies. Moffitt Cancer Center researchers, in collaboration with colleagues from the University of Maryland and the Institute for Research in Biomedicine Barcelona, suggest that lowering the pH inside cancer cells to make it more acidic can slow down the growth and spread of the disease, and possibly provide new options for treatment.

Released:
16-Aug-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
NEW_RutgersCancerInst_2018_sm2.jpg

Article ID: 699110

Reaffirming its Role as a Statewide Resource, Rutgers Cancer Institute of New Jersey is Redesignated as the State’s Only Comprehensive Cancer Center

Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey, the state’s only Comprehensive Cancer Center as designated by the National Cancer Institute (NCI), has successfully renewed this designation.

Released:
16-Aug-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
DanielDiMaioMDPhD.jpg
  • Embargo expired:
    16-Aug-2018 11:00 AM EDT

Article ID: 699077

Discovery May Help Provide Clues for Fighting and Treating HPV

Yale Cancer Center

Yale Cancer Center (YCC) scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus (HPV) infects cells.

Released:
15-Aug-2018 7:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 699039

Two for One

University of New Mexico Comprehensive Cancer Center

Neuroendocrine cancer is rare and hard to diagnose – and it can be difficult to treat and to survive. To help make more accurate diagnoses more quickly, the UNM Department of Radiology recently started using a new, injectable imaging agent to pinpoint neuroendocrine tumors. And in October, UNM Cancer Center will begin offering a new treatment that uses part of that imaging agent to fight the tumors.

Released:
16-Aug-2018 5:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
150401_LItton_J.jpg
  • Embargo expired:
    15-Aug-2018 5:00 PM EDT

Article ID: 699023

PARP inhibitor improves progression-free survival in patients with advanced breast cancers and BRCA mutations

University of Texas M. D. Anderson Cancer Center

In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.

Released:
15-Aug-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
SEP - Caren Brinkema.jpg

Article ID: 698978

Fred Hutch Wins $1.26 Million Grant to Boost Science and Education Efforts

Fred Hutchinson Cancer Research Center

Fred Hutchinson Cancer Research Center announced it received a five year Science Education Partnership Award (SEPA) from The National Institute of General Medical Sciences (NIGMS), worth $1.26 million.

Released:
15-Aug-2018 2:20 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Education


Showing results

110 of 1084





Chat now!